PETRILLO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 5.613
AS - Asia 2.711
SA - Sud America 2.228
EU - Europa 850
AF - Africa 130
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.555
Nazione #
US - Stati Uniti d'America 5.476
BR - Brasile 1.997
SG - Singapore 1.553
CN - Cina 390
HK - Hong Kong 312
IT - Italia 253
UA - Ucraina 162
DE - Germania 106
AR - Argentina 82
TR - Turchia 68
VN - Vietnam 63
MX - Messico 54
GB - Regno Unito 50
EC - Ecuador 49
RU - Federazione Russa 48
CA - Canada 45
ZA - Sudafrica 39
BD - Bangladesh 38
UZ - Uzbekistan 38
FR - Francia 36
FI - Finlandia 35
MA - Marocco 29
IN - India 25
IQ - Iraq 25
VE - Venezuela 25
JP - Giappone 24
CO - Colombia 21
PK - Pakistan 20
CL - Cile 18
NL - Olanda 18
AZ - Azerbaigian 17
AT - Austria 16
PL - Polonia 16
ES - Italia 15
KR - Corea 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
SE - Svezia 14
AU - Australia 13
KE - Kenya 13
BE - Belgio 12
JO - Giordania 12
KZ - Kazakistan 12
PE - Perù 12
ID - Indonesia 11
EG - Egitto 10
NP - Nepal 10
PY - Paraguay 10
OM - Oman 9
UY - Uruguay 9
IE - Irlanda 8
IL - Israele 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
KW - Kuwait 7
PS - Palestinian Territory 7
RO - Romania 7
AO - Angola 6
CH - Svizzera 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
LB - Libano 6
PA - Panama 6
AL - Albania 5
DZ - Algeria 5
HN - Honduras 5
KG - Kirghizistan 5
NI - Nicaragua 5
BH - Bahrain 4
BN - Brunei Darussalam 4
GR - Grecia 4
JM - Giamaica 4
MD - Moldavia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
LT - Lituania 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
IR - Iran 2
MK - Macedonia 2
MU - Mauritius 2
PH - Filippine 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BW - Botswana 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GN - Guinea 1
GS - Georgia del Sud e Isole Sandwich Australi 1
Totale 11.541
Città #
Dallas 2.743
Singapore 878
Chandler 831
Hong Kong 310
Princeton 240
Beijing 143
São Paulo 136
Ashburn 135
Wilmington 114
The Dalles 91
Columbus 84
Shanghai 84
Rio de Janeiro 66
Belo Horizonte 50
New York 46
Los Angeles 44
Santa Clara 44
Tashkent 37
Brasília 35
Sassari 33
Salvador 30
Council Bluffs 29
Falls Church 29
Ho Chi Minh City 29
Campinas 28
Helsinki 26
Curitiba 24
Rome 24
Guarulhos 23
Porto Alegre 23
Tokyo 23
San Francisco 22
Munich 20
Norwalk 20
Toronto 18
Johannesburg 17
Manaus 17
Sorocaba 17
Frankfurt am Main 16
Istanbul 16
Quito 16
Baku 15
Boardman 15
Brooklyn 15
Ribeirão Preto 15
Seoul 15
Contagem 14
Nuremberg 14
Ankara 13
Ann Arbor 13
Campo Grande 13
Cape Town 13
Osasco 13
Praia Grande 13
Amman 12
Brussels 12
Falkenstein 12
Jacksonville 12
Nairobi 12
Recife 12
Warsaw 12
Düsseldorf 11
Goiânia 11
Mexico City 11
Montreal 11
Tianjin 11
Uberlândia 11
Atlanta 10
Denver 10
Guayaquil 10
Santo André 10
Baghdad 9
Bogotá 9
London 9
Montevideo 9
Orem 9
Rio Grande 9
Vila Velha 9
Volta Redonda 9
Boston 8
Buffalo 8
Caxias do Sul 8
Cotia 8
Dhaka 8
Florianópolis 8
Haikou 8
João Pessoa 8
Mauá 8
Pelotas 8
Ribeirão das Neves 8
São José dos Campos 8
Vienna 8
Vitória da Conquista 8
Várzea Paulista 8
Barbianello 7
Buenos Aires 7
Canoas 7
Cuiabá 7
Dourados 7
Foz do Iguaçu 7
Totale 7.216
Nome #
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project 299
Exploring Vascular Complications in Ovarian Cancer Surgery: A Narrative Literature Review with a New Management Proposal Algorithm 289
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 275
Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer 261
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 251
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 159
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 147
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 134
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 125
Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study 125
A case of isolated ovarian recurrence from vulvar carcinoma 124
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma 121
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 120
Efficacy and effectiveness of the bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis 118
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 118
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer 117
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 117
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 116
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 115
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 115
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience 110
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 110
Comparison of perioperative outcomes between standard laparoscopic and robotic-assisted approach in patients with rectosigmoid endometriosis 108
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 106
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 106
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 103
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study 102
Conservatively treated glassy cell carcinoma of the cervix 99
The impact of COVID-19 lockdown on admission to gynecological emergency department: results from a a multicenter italian study 97
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment 97
CD133 antigen expression in ovarian cancer 96
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 95
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 93
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 89
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: The experience at Gemelli hospital and a literature review 87
Native tissue repair (NTR) versus transvaginal mesh interventions for the treatment of anterior vaginal prolapse: Systematic review and meta-analysis 85
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 84
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study 83
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer 83
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 83
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 82
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer 80
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community 80
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 80
Fetal Growth and Neonatal Outcomes in Pregestational Diabetes Mellitus in a Population with a High Prevalence of Diabetes 80
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer 79
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series 79
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 79
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 79
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature 77
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness 76
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 76
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy 76
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes 75
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 74
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 74
Vulvar squamous cell carcinoma with sarcoma-like stroma: A case report and review of the literature 73
Self-reported long-term autonomic function after laparoscopic total mesometrial resection for early-stage cervical cancer: A multicentric study 72
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 72
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 71
Glassy cell carcinoma of the endometrium: A case report and review of the literature 71
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer 71
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 71
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis 71
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 71
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results 71
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy 70
Novel targets for VEGF-independent anti-angiogenic drugs 70
Ovarian low and high grade serous carcinomas: Hidden divergent features in the tumor microenvironment 69
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 69
Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer 69
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 68
Targeting the hallmarks of ovarian cancer: The big picture 68
Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study 67
Non-catalytic region of tyrosine kinase adaptor protein 2 (Nck2) pathways as factor promoting aggressiveness in ovarian cancer 67
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 67
Impact of postoperative cardiovascular complications on 30‐day mortality after major abdominal surgery: an international prospective cohort study 66
Lidocaine spray vs mepivacaine local infiltration for suturing 1st/2nd grade perineal lacerations: a randomised controlled non-inferiority trial 66
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients 65
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 65
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? 65
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies 65
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer 64
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study 64
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study 64
Incidence and predictive factors for complications after uterine leiomyoma embolization 63
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer 63
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome 63
Secondary cytoreduction in ovarian cancer: who really benefits? 62
Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients 62
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 61
Expression and subcellular localization of CRH and its receptors in human endometrial cancer 60
Standardized training programmes for advanced laparoscopic gynaecological surgery 60
Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): A multicentric experience 60
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 60
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 60
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study 60
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 59
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 59
Novel VEGF-independent strategies targeting tumor vasculature: Clinical aspects 58
Totale 9.300
Categoria #
all - tutte 54.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 5 0 152 122 15 7
2021/2022561 14 7 9 13 25 22 11 46 61 49 68 236
2022/20231.454 151 54 20 266 128 248 2 211 286 12 50 26
2023/2024332 81 31 17 11 23 15 15 35 0 3 27 74
2024/20254.406 59 33 250 123 211 174 307 950 1.522 496 175 106
2025/20264.655 226 1.300 1.835 579 652 63 0 0 0 0 0 0
Totale 11.779